| 1 |
Luo P, Li S, Long X. N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy. Biochim Biophys Acta Rev Cancer 2023;1878:188873. [PMID: 36842764 DOI: 10.1016/j.bbcan.2023.188873] [Reference Citation Analysis]
|
| 2 |
Shang QX, Kong WL, Huang WH, Xiao X, Hu WP, Yang YS, Zhang H, Yang L, Yuan Y, Chen LQ. Identification of m6a-related signature genes in esophageal squamous cell carcinoma by machine learning method. Front Genet 2023;14:1079795. [PMID: 36733344 DOI: 10.3389/fgene.2023.1079795] [Reference Citation Analysis]
|
| 3 |
Deng J, Lin J, Liu C, Li J, Cai J, Zhou X, Li X. N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma. Sci Rep 2022;12:21082. [PMID: 36473947 DOI: 10.1038/s41598-022-25698-x] [Reference Citation Analysis]
|
| 4 |
Mao S, Chen Z, Wu Y, Xiong H, Yuan X, Han H. Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung Adenocarcinoma. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/1285632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Guo Y, Bai Y, Wang L, Xu Z, Wang X, Wang W. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer. Medicine (Baltimore) 2022;101:e29818. [PMID: 35777046 DOI: 10.1097/MD.0000000000029818] [Reference Citation Analysis]
|
| 6 |
Li XY, Zhao ZJ, Wang JB, Shao YH, Hui-Liu, You JX, Yang XT. m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma. Front Bioeng Biotechnol 2022;10:849756. [PMID: 35620469 DOI: 10.3389/fbioe.2022.849756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Liu T, Li H, Du G, Ma J, Shen J, Zhao H, Luo F, Li H. Comprehensive analysis of m6A regulator-based methylation modification patterns characterized by distinct immune profiles in colon adenocarcinomas. Gene 2022;821:146250. [PMID: 35151825 DOI: 10.1016/j.gene.2022.146250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Duan Y, Yu C, Yan M, Ouyang Y, Ni S. m6A Regulator-Mediated RNA Methylation Modification Patterns Regulate the Immune Microenvironment in Osteoarthritis. Front Genet 2022;13:921256. [PMID: 35812736 DOI: 10.3389/fgene.2022.921256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
